AtaCor Medical
PrivateLast Round
Financing
Oct 6, 2025
Est. Valuation
$80M
Total Funding Raised
$61.8M
Company Overview
AtaCor Medical operates in Healthcare & Life Sciences and is based in San Clemente, California. Its latest recorded funding round was a Financing round in October 2025.
AtaCor Medical is a medical device company that develops extravascular cardiac pacing and defibrillation lead systems designed to provide alternatives to traditional transvenous devices.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AtaCor Medical Comparables
Compare AtaCor Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NewPace | 84% | |
| Medtronic | 78% | |
| Cortex, Inc. | 77% |
For institutional investors. Book with your work email.
AtaCor Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Financing | Oct 6, 2025 | ||||
| Series C | Apr 24, 2024 | ||||
| Series B | Apr 28, 2020 | ||||
| Series A | Sep 18, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AtaCor Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BayMed Venture Partners | Series C, Financing |
| CHV | Series C, Series B |
| Arboretum Ventures | Financing, Series C |
| Hatteras Venture Partners | Series B, Series C, Financing |
| aMoon | Series B, Series A |
| Longview Partners | Series B |
| Catalyst Health Ventures | Series B, Series C, Financing |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 21, 2026
Partnering with Abbott on investigational extravascular ICD system.
- Oct 6, 2025
$75M round raised
For institutional investors. Book with your work email.
AtaCor Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AtaCor Medical's valuation, stock price, and market status.
Is AtaCor Medical a public or private company?
AtaCor Medical is a private company.
What is the current stock price of AtaCor Medical?
AtaCor Medical is a private company, so its shares have no public market price. Caplight tracks AtaCor Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AtaCor Medical worth (valuation)?
AtaCor Medical's valuation is estimated at $80.0M based on funding round data.
Can I buy AtaCor Medical stock?
AtaCor Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AtaCor Medical's last funding round?
AtaCor Medical's most recent funding round was Financing on October 6, 2025.
Who are the main investors in AtaCor Medical?
Key investors in AtaCor Medical include CHV, Arboretum Ventures, aMoon, Longview Partners, Broadview Ventures.
Will AtaCor Medical IPO soon?
No public IPO plans have been announced for AtaCor Medical.
How can I track AtaCor Medical secondary market activity?
Caplight tracks bids, offers, and trades in AtaCor Medical's shares on secondary markets.